Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy
The Value of Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy. A Dutch Randomized Controlled Multicentre Trial.
Sponsor: Borstkanker Onderzoek Groep
Terminated
slow accrual rate
Other terminated trials from Borstkanker Onderzoek Groep
A NA clinical study on Breast Neoplasms, this trial is terminated or withdrawn. The trial is conducted by Borstkanker Onderzoek Groep and has accumulated 8 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 3 earlier versions
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE3 → NA
-
Apr 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE3
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Borstkanker Onderzoek Groep
- Dutch Cancer Society
- Maastricht University
- Maastricht University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .